DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Fry TJ, Shah NN, Orentas RJ. et al.
CD22‐targeted CAR T cells induce remission in B‐ALL that is naïve or resistant to CD19‐targeted CAR immunotherapy.
Nat Med 2018;
24: 20-28
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.